Various clinicopathological variables were identified as the risk factors for EC, including advanced age, tumor grade, size, histological subtype, the depth of uterine myometrial invasion, the cervical stromal involvement, estrogen receptor (ER) and progesterone receptor (PR) expression, and lymphovascular space invasion (LVSI) (2). This evidence concerns the gene ESR1 and neoplasm.